| Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function JK Duong, SS Kumar, CM Kirkpatrick, LC Greenup, M Arora, TC Lee, ... Clinical pharmacokinetics 52 (5), 373-384, 2013 | 148 | 2013 |
| Metformin therapy in patients with chronic kidney disease JK Duong, DM Roberts, TJ Furlong, SS Kumar, JR Greenfield, ... Diabetes, Obesity and Metabolism 14 (10), 963-965, 2012 | 94 | 2012 |
| Therapeutic potential of citrulline as an arginine supplement: a clinical pharmacology review J Rashid, SS Kumar, KM Job, X Liu, CD Fike, CMT Sherwin Pediatric Drugs 22 (3), 279-293, 2020 | 79 | 2020 |
| State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development V Yellepeddi, J Rower, X Liu, S Kumar, J Rashid, CMT Sherwin Clinical Pharmacokinetics, 1-13, 2018 | 62 | 2018 |
| Renal Clearance in Newborns and Infants: Predictive Performance of Population Based Modeling for Drug Development S Wang, SS Kumar, CM Sherwin, R Ward, G Baer, GJ Burkart, Y Wang, ... Clinical Pharmcology and Therapeutics, 2018 | 38 | 2018 |
| Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin … N Diasinos, M Baysari, S Kumar, RO Day Internal medicine journal 45 (1), 55-62, 2015 | 26 | 2015 |
| The safety and pharmacokinetics of metformin in patients with chronic liver disease FC Smith, SL Stocker, M Danta, JE Carland, SS Kumar, Z Liu, ... Alimentary Pharmacology & Therapeutics 51 (5), 565-575, 2020 | 23 | 2020 |
| Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study JNA Matthew W Linakis, Sarah F Cook, Shaun S Kumar, Xiaoxi Liu, Diana G ... Clinical pharmacokinetics, 1-12, 2018 | 23* | 2018 |
| A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function JK Duong, M Kroonen, SS Kumar, HL Heerspink, CM Kirkpatrick, ... European journal of clinical pharmacology 73 (8), 981-990, 2017 | 22 | 2017 |
| The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non‐Indigenous Australians with type 2 diabetes mellitus JK Duong, SS Kumar, TJ Furlong, CM Kirkpatrick, GG Graham, ... British journal of clinical pharmacology 79 (4), 617-623, 2015 | 15 | 2015 |
| Comparing dose prediction software used to manage gentamicin dosing C Wong, SS Kumar, GG Graham, EJ Begg, PKL Chin, J Brett, JE Ray, ... Internal medicine journal 43 (5), 519-525, 2013 | 15 | 2013 |
| Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model JE Rower, C Stockmann, MW Linakis, SS Kumar, X Liu, EK Korgenski, ... BMJ paediatrics open 1 (1), 2017 | 14 | 2017 |
| Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration FC Smith, SS Kumar, TJ Furlong, SV Gangaram, JR Greenfield, ... American Journal of Kidney Diseases 68 (6), 990-992, 2016 | 13 | 2016 |
| Trends in metformin utilisation and dose appropriateness in Australia J Moon, SS Kumar, GG Graham, MT Baysari, KM Williams, W Chen, ... European journal of clinical pharmacology 72 (12), 1489-1496, 2016 | 8 | 2016 |
| Extrapolation of adult efficacy to pediatric patients with chemotherapy‐induced nausea and vomiting JD Momper, MT Heinrichs, K Krudys, D Griebel, S Kumar, I Kim, ... The Journal of Clinical Pharmacology 60 (6), 775-784, 2020 | 6 | 2020 |
| Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients KM Job, JK Roberts, EY Enioutina, SM IIIamola, SS Kumar, J Rashid, ... Expert opinion on drug metabolism & toxicology, 2021 | 5 | 2021 |
| The clinical utility of pharmacometric models SS Kumar, E Biltaji, R Bies, CM Sherwin British journal of clinical pharmacology 84 (7), 1413, 2018 | 5 | 2018 |
| The safe use of metformin in heart failure patients both with and without T2DM: a cross‐sectional and longitudinal study G Chowdhury, JE Carland, S Kumar, N Olsen, G Graham, ... British Journal of Clinical Pharmacology, 2023 | 4 | 2023 |
| The Reliability of Histamine Pharmacodynamic Response Phenotype Classification in Children With Allergic Disease SS Kumar, X Liu, CM Sherwin, BL Jones Frontiers in Pharmacology 11, 227, 2020 | 3 | 2020 |
| Exposure‐Response Relationships for Pralsetinib in Patients with RET‐Altered Thyroid Cancer or RET Fusion‐Positive Nonsmall Cell Lung Cancer N Kassir, D McDougall, D Kuruvilla, S Kim, S Kumar, A Rahman, T Ruf, ... The Journal of Clinical Pharmacology, 2024 | 2 | 2024 |
Richard O. DayProfessor of Clinical Pharmacology, University of New South Wales and St Vincent's Hospital, Sydneyایمیل تأیید شده در unsw.edu.au